MS Research Progress Takes Center Stage at American Academy of Neurology’s Annual Meeting/About-the-Society/News/MS-Research-Progress-Takes-Center-Stage-at-America … read morePosted At: National MS Society
Italian Researchers Find that MS Disease-Modifying Therapies Reduce the Risk of Future MS Progressio
Italian Researchers Find that MS Disease-Modifying Therapies Reduce the Risk of Future MS Progressio/About-the-Society/News/Italian-Researchers-Find-that-MS-Disease-Modifying … read morePosted At: National MS Society
What are the early signs of MS?The early signs and symptoms of MS can vary widely, and some can be significantly challenging or debilitating. Here, learn more about the early symptoms of MS, such...
Society Responds to Copay Accumulator Programs – Barriers to MS Medications/About-the-Society/News/Society-Responds-to-Copay-Accumulator-–-Barriers-t … read morePosted At: National MS Society
Polyunsaturated fatty acids and the risk of multiple sclerosisMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
- Next story Results from Trial Comparing Teriflunomide and Rebif in Relapsing MS Do Not Meet Primary Goal
- Previous story Possible Safety Issue Being Investigated with Novartis Pill Gilenya
Join Our Mailing List
- World’s Largest MS Research Conference: Understanding MS and New Strategies to Restore Function
- Conceptual framework to study role of exercise in multiple sclerosis
- Insights into microbiome research 3: Who’s there versus what are they doing?
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosis
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting protein
- Animal models of multiple sclerosis: From rodents to zebrafish
- Inclusion criteria used in trials of people with progressive multiple sclerosis